Assessment of glypican-3 immune expression in ameloblastoma, ameloblastic fibroma, ameloblastic carcinoma (pilot study)

Beni-Suef University Journal of Basic and Applied Sciences

Table 2 Describing area percent of GPC-3 for the 4 study groups

	Mean	Std. Deviation	Std. Error	95% Confidence Interval for Mean		Min	Max	F	p value
	Mean	Std. Deviation	Std. Error	Lower Bound	Upper Bound	Min	Max	F	p value
AB	33.95^b	7.21607	3.22712	24.99	42.90	25.22	41.12	86.277	0.000
AF	5.65^a	1.10591	0.49458	4.28	7.02	4.48	6.96
ABC	58.77^c	10.62718	4.75262	45.57	71.96	40.23	67.33
DF	1.34^a	0.50613	0.22635	0.71	1.97	0.79	1.94

*Significant at p < 0.05
Means with different superscript letters are significantly different (Tukey’s post hoc test)